Effects of the inhibition of cyclooxygenase-2 on human esophageal cancer cells: Inhibition of cell proliferation and induction of apoptosis

Pathology and Oncology Research

Volumn 16, Issue 1, 2010, Pages 39-45

  Zhang, Li ^a,d   Tu, Jun ^b   Yu, Zhong Lin ^a   Wu, Yong Dong ^a   Xu, Cai Min ^c   Zhang, Shu Tian ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Acidum acetil salicylicum (aspirin); Apoptosis; Cell proliferation; Cyclooxygenase 2 (COX 2); Esophageal squamous cell carcinoma (ESCC); Synergistic effect

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME INHIBITION; ESOPHAGUS CANCER; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; ESOPHAGEAL NEOPLASMS; FLOW CYTOMETRY; HUMANS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 77949654755     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9185-6     Document Type: Article

References (25)

1. Roth JA, Putnam JB, Rich TA et al (1997) Cancer of the esophagus. In: Devita VT, Hellman S Jr, Rosenberg SA (eds) Cancer: principles and practice of the oncology. Lippincott-Raven, Philadephia, pp 980-1020
2. CJ Buskens BP Van Rees A Sivula, et al. 2002 Prognostic significance of elevated cyclooxygensase-2 expression in patient with adenocarcinoma of the esophagus Gastroenterology 122 1800 1807 10.1053/gast.2002.33580 1:CAS:528:DC%2BD38Xlt12gs70%3D 12055587
3. YS Bakhle 2001 COX-2 and cancer: a new approach to an old problem Br J Pharmacol 134 1137 1150 10.1038/sj.bjp.0704365 1:CAS:528:DC%2BD3MXosl2qsrc%3D 11704632
4. JB Méric S Rottey K Olaussen, et al. 2006 Cyclooxygenase-2 as a target for anticancer drug development Crit Rev Oncol Hematol 59 51 64 10.1016/j.critrevonc.2006.01.003 16531064 (Pubitemid 43903278)
5. ER Fearon B Volgelstein 1990 A genetic model for colorectal tumorigenesis Cell 61 759 767 10.1016/0092-8674(90)90186-I 1:CAS:528:DyaK3cXktlyhtrg%3D 2188735
6. LS Wang KC Chow YC Wu 2002 Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells Scand J Gastroenterol 37 467 475 10.1080/003655202317316114 1:CAS:528:DC%2BD38Xjs12nt78%3D 11989839 (Pubitemid 34274332)
7. S Kase M Osaki S Honjo, et al. 2004 Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma Pathobiology 71 84 92 10.1159/000074421 1:CAS:528:DC%2BD2cXhtV2qtw%3D%3D 14707443 (Pubitemid 38056728)
8. N Hashimoto M Inayama M Fujishima, et al. 2007 Clinicopathologic significance of expression of cyclooxygenase-2 in human esophageal squamous cell carcinoma Hepatogastroenterology 54 758 760 1:CAS:528:DC%2BD2sXnslSltb4%3D 17591056
9. I Bantounas LA Phylactou JB Uney 2004 RNA interference and the use of small interfering RNA to study gene function in mammalian systems J Mol Endocrinol 33 545 557 10.1677/jme.1.01582 1:CAS:528:DC%2BD2MXis1amsw%3D%3D 15591019 (Pubitemid 40057555)
10. A Strillacci C Griffoni E Spisni, et al. 2006 RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cells Br J Cancer 94 1300 1310 10.1038/sj.bjc.6603094 1:CAS:528:DC%2BD28XktVaht7o%3D 16622456
11. GS Charames B Bapat 2006 Cyclooxygenase-2 knockdown by RNA interference in colon cancer Int J Oncol 28 543 549 1:CAS:528:DC%2BD28XhsFSns7s%3D 16391811
12. M Abdelrahim S Safe C Baker, et al. 2006 RNAi and cancer: Implication and applications Journal of RNAi and Gene Silencing 2 136 145 1:CAS:528: DC%2BD28XjsVCitL8%3D 19771215
13. SS Husain IL Szabo AS Tamawski 2002 NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action Am J Gastroentero l 97 542 553 10.1111/j.1572-0241.2002.05528.x 1:CAS:528:DC%2BD38XjtFyrs70%3D
14. CS Williams M Mann RN DuBois 1999 The role of cyclooxygenases in inflammation, cancer, and development Oncogene 18 7908 7916 10.1038/sj.onc. 1203286 1:CAS:528:DC%2BD3cXks1KlsA%3D%3D 10630643
15. H Sumimoto 2005 Use of RNA interference technology for cancer specific gene silencing Ann Cancer Res Therap 13 23 25
16. B Dalby S Cates A Harris, et al. 2004 Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications Methods 33 95 103 10.1016/j.ymeth.2003.11.023 1:CAS:528: DC%2BD2cXjs1Cgsrs%3D 15121163 (Pubitemid 38569654)
17. X Liu P Li ST Zhang H You, et al. 2008 COX-2 mRNA expression in esophageal squmous cell carcinoma (ESCC) and effect by NSAID Dis Esophagus 21 9 14 1:CAS:528:DC%2BD1MXmvFKisw%3D%3D 18197933
18. KC Zimmermann M Sarbia AA Weber F Borchard HE Gabbert K Schrör 1999 Cyclooxygenase-2 expression in human esophageal carcinoma Cancer Res 59 198 204 1:CAS:528:DyaK1MXms1ejsg%3D%3D 9892207
19. M Li R Lotan B Levin, et al. 2000 Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention Epidemiol Biomarkers Prev 9 545 549 1:CAS:528:DC%2BD3cXksVGjt7Y%3D
20. M Tsujii RN DuBois 1995 Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 Cell 83 493 501 10.1016/0092-8674(95)90127-2 1:CAS:528:DyaK2MXpt1Olt7w%3D 8521479
21. H Zhi L Wang J Zhang, et al. 2006 Significance of COX-2 expression in human esophageal squamous cell carcinoma Carcinogenesis 27 1214 1221 10.1093/carcin/bgi304 1:CAS:528:DC%2BD28XmsVOrsro%3D 16352617 (Pubitemid 43985436)
22. H Sheng J Shao JD Morrow, et al. 1998 Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells Cancer Res 56 362 366
23. JR Brown RN DuBois 2005 COX-2: a molecular target for colorectal cancer prevention J Clin Oncol 23 2840 2855 10.1200/JCO.2005.09.051 1:CAS:528:DC%2BD2MXktleqt7w%3D 15837998 (Pubitemid 46179475)
24. ML Smith G Hawcroft MA Hull 2000 The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action Eur J Cancer 36 664 674 10.1016/S0959-8049(99)00333-0 1:CAS:528:DC%2BD3cXitVSnsL8%3D 10738133 (Pubitemid 30156854)
25. P Li ST Zhang ZL Yu, et al. 2009 Effects of cyclooxygenase-2 non-selective and selective inhibitors on proliferation inhibition and apoptosis induction of esophageal squamous carcinoma cells Dis Esophagus 22 21 31 10.1111/j.1442-2050.2008.00836.x 1:STN:280:DC%2BD1M7itVGmug%3D%3D 18564172